Institutional Ownership Calliditas Therapeutics Ab (CALT)
This table provides information about the institutional ownership of Calliditas Therapeutics Ab (CALT). We have compiled data on the 6 institutions that hold shares in the stock, with a total of 20,321 shares, which have been reported (via 13F filing form) to have a value of $812,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Crossmark Global Holdings, Inc.
|
Nov 04, 2024 Q3 2024 |
16,117
shares
|
$644,680
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Advisors Preferred, LLC
Rockville, MD |
Oct 15, 2024 Q3 2024 |
2,022
shares
|
$80,880
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Simplex Trading, LLC
|
Nov 08, 2024 Q3 2024 |
1,826
shares
|
$73,040
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
303
shares
|
$12,120
0.0% of portfolio
|
Q3 2024
Added 50.0%
|
|
|
Missouri Trust & Investment CO
Springfield, MO |
Nov 05, 2024 Q3 2024 |
35
shares
|
$1,400
0.0% of portfolio
|
Q4 2021
New holding
|
|
|
Nalls Sherbakoff Group, LLC
Knoxville, TN |
Apr 09, 2024 Q4 2023 |
18
shares
|
$720
0.0% of portfolio
|
Q4 2023
Reduced 48.57%
|